Please login to the form below

Not currently logged in
Email:
Password:

Brintellix

This page shows the latest Brintellix news and features for those working in and with pharma, biotech and healthcare.

EMA backs Lundbeck's Brintellix in depression

EMA backs Lundbeck's <b>Brintellix</b> in depression

EMA backs Lundbeck's Brintellix in depression. Drug recommended for approval to treat major depressive episodes in adults. ... In the latest round of EU drug recommendations, Lundbeck won backing for the use of Brintellix in the treatment of adult

Latest news

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Bayer’s Barbara Jaszewski joins Lundbeck Bayer’s Barbara Jaszewski joins Lundbeck

    In addition, Lundbeck also has Brintellix ( vortioxetine) under review by the EMA, while a once-monthly version of schizophrenia drug Abilify ( aripiprazole) is also due to launch during 2013.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Liberation

'Progressive', 'cutting edge' – words used to describe Liberation. We believe looking forward is essential to delivering successful and innovative...

Latest intelligence

Online Physician Communities
M3 improves personalisation of pharma engagement with doctors
Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck
Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge
Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...